DEC 12, 2019 7:30 PM PST

Probiotics Treat Alcohol-Induced Liver Injury

WRITTEN BY: Annie Lennon

Alcoholic liver injury is caused by overconsumption of alcohol, something that can lead to serious diseases such as liver steatosis, liver cirrhosis and liver cancer. While certain forms of these conditions are known to be irreversible, a recent study has found that probiotics may offer a solution. 

So far, exactly how Alcoholic Liver Disease (ALD) develops is unknown. However, it has been proposed that both long-term and excessive consumption of alcohol may lead to changes in the diversity of bacteria found in the intestines, thus reducing the intestinal mucus layer. Consumption of alcohol may also affect the expression of a certain protein which then leads to an intestine barrier dysfunction, as well as oxidative damage to liver tissue. 

Given this possible interaction between the liver and microbiome, researchers from Jilin Agricultural University, China, planned to see how changes to the microbiome may impact ALD. To do so, they fed 64 mice alcohol for 8 weeks, alongside granules of Lactobacillus rhamnosus during the last two weeks in low, medium or high doses together with a high fat diet. 

At the end of the study period, the researchers found that administration of Lactobacillus rhamnosus dose-dependently improved alcohol-induced liver injury by decreasing the accumulation of fat in the liver, as well as its inflammatory response. Also improving general damage to the liver, they found that the probiotic effect of the bacteria restored a healthy balance to the microbiome, and reduced the quantity of gram-negative bacteria present, while increasing the number of gram-positive bacteria such as ileum and cecum. 

The researchers said, “Our findings demonstrate that 0.1 g/(day·mouse) LGG granules can prevent alcohol-induced expansion of Gram-negative bacteria in ileum and cecum and decrease enterogenous endotoxin and inflammatory response, and then ameliorated liver injury.”

Michael Zemel, Journal of Medicinal Food Editor-in-Chief, said, “This demonstration of the impact of a probiotic intervention correcting alcohol-induced dysbiosis and reducing liver inflammation and fat accumulation has exciting potential in the prevention and treatment of alcohol-induced liver disease as well as non-alcoholic fatty liver disease.”

Although exciting results that may one day yield new treatment options for ALD, the researchers highlighted that further research is needed to properly understand the medicinal potential of probiotics to treat ALD. In particular, they noted that a more representative clinical sample is needed. 

 

Sources: Journal of Medicinal Food, Nutraingredients and EurekAlert

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 21, 2020
Drug Discovery & Development
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
SEP 21, 2020
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
The World Health Organization has endorsed a protocol to put African herbal medicines through clinical trials as possibl ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 08, 2020
Neuroscience
Psychedelic DMT Improves Memory by Neurogenesis
NOV 08, 2020
Psychedelic DMT Improves Memory by Neurogenesis
Researchers from the Complutense University of Madrid in Spain have found that dimethyltryptamine (DMT), the psychoactiv ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
NOV 28, 2020
Microbiology
Potential Treatment ID'ed for Emerging Viral Disease
NOV 28, 2020
Potential Treatment ID'ed for Emerging Viral Disease
A mosquito-borne virus called VEEV has been emerging in South America. It causes symptoms that make it difficult to dist ...
Loading Comments...